Company
BIMINI Biotech
- Biotech
- Location:
- NV Leiden (Leiden, Netherlands)
Description
BIMINI Biotech develops first-in-class small-molecule therapeutics modulating the Wiskott–Aldrich Syndrome protein for oncology and autoimmune disease indications, supplying preclinical drug candidates to biomedical researchers and clinical developers.
Related
Pharmasum TherapeuticsPharmasum Therapeutics develops small-molecule drugs for neurological diseases, advancing proprietary DYRK1A inhibitor PST-674 for…
Laigo BioLaigo Bio develops SureTACs, bispecific protein-degradation therapeutics that remove disease-driving cell-surface proteins for oncology and…
ONCOMATRYX BIOPHARMA SLOncomatryx develops biotechnology programs focused on modulating the tumor microenvironment.
Captor TherapeuticsCaptor Therapeutics builds targeted protein degradation therapeutics and drug discovery platforms to develop degrader medicines for cancer…
ATXA THERAPEUTICSATXA THERAPEUTICS develops selective small-molecule thromboxane receptor (TP) antagonists and clinical candidate NTP42 for cardiopulmonary…
Kyverna Therapeutics ($KYTX)Kyverna Therapeutics develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff…
Ditto BiosciencesDitto Biosciences discovers therapeutic molecules by studying parasite biology and applying experimental plus computational methods to…
AplagonAplagon develops first-in-class therapeutics for thromboinflammatory diseases, focusing on clinical-stage drug APAC to treat thrombotic and…
Genesis TherapeuticsGenesis Therapeutics develops AI-driven molecular design models and an integrated platform to generate, evaluate, and optimize…
Generate:BiomedicinesGenerate:Biomedicines designs and engineers therapeutic proteins and cell therapies by combining machine learning with biological…
Fraunhofer Institute for Translational Medicine and Pharmacology ITMPFraunhofer ITMP conducts translational medicine and pharmacology research across preclinical, clinical, discovery, and infection-focused…
Kyverna Therapeutics (San Diego)Kyverna Therapeutics (San Diego) develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T…